Vincent O'Neill, Chief Medical Officer at BioXcel Therapeutics, Inc. (BTAI), sold 47,100 shares at $56.60 ($2.6M) on 2021-02-17, disclosed to the SEC on 2021-02-19.
Open-market sale of $2.6M BTAI by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.77 | 2,300 | $124K | 4.7% |
| 2 | $54.45 | 5,655 | $308K | 11.7% |
| 3 | $54.45 | 5,655 | $308K | 11.7% |
| 4 | $55.55 | 6,872 | $382K | 14.6% |
| 5 | $55.55 | 6,872 | $382K | 14.6% |
| 6 | $56.60 | 9,573 |
| $542K |
| 20.7% |
| 7 | $56.60 | 9,573 | $542K | 20.7% |
| 8 | $57.17 | 600 | $34K | 1.3% |
| Total | $55.65 avg | 47,100 | $2.6M | 100% |
| Filing → |
| BTAI | SELL | 2024-09-17 | $95 | — | Filing → |
| BTAI | SELL | 2024-06-18 | $200 | — | Filing → |
| BTAI | SELL | 2024-04-08 | $432 | — | Filing → |